What impact does integrative cancer approaches have as actual cancer treatment–beyond symptom control? And how does one most efficiently and effectively go about the decision-making process? Here’s a practical framework to consider.
Guest post contributor Brad Power is an expert in the field of business process innovation. He is applying his own cancer experience to help usher in truly personalized cancer care and the engagement of patient ‘scientists’.
The future of cancer treatment is a highly personalized, N of 1 model of care, specific to each unique individual and each unique tumor a person is hosting.
Poet Matt Mumber, an integrative radiation oncologist serving a rural Georgia community, is among a long list of physician poets—past and present—that include Oliver Wendall Holmes, John Keats, and Rafael Campo. Here are five poems from Matt Mumber’s latest book, The Attending.
I’ve learned a few things over the 30 years since being diagnosed with cancer. These personal lessons, combined with what I’ve gleaned from 19 years as a cancer coach, greatly shapes my ever-growing understanding of cancer—and its prevention and control.
New epidemiological prospective study looking at incidence of pancreatic cancer shows that a plant-based diet can create a pro-cancer environment or anticancer environment, depending on quality of diet.
Researchers at Tel Aviv University report results of a new study showing the risk of metastatic cancer can be reduced by 72% through vigorous aerobic exercise.
Glenn Sabin’s comprehensive anticancer diet list. Learn Glenn’s approach to buying produce and what definitely needs to be organic and what is okay to buy conventionally grown. Here’s Glenn’s perspective on animal protein choices, including select omega-3-rich cold water fish.
Cancer remains the scariest and most anxiety-provoking 6-letter word I know. But we now have more tools than ever to proactively and pragmatically approach a diagnosis while better controlling emotions—namely fear and anxiety, which can lead to depression.
The business of cancer care is complex, and not always, shall we say, fair and transparent to patients … especially when it comes to treatment costs. This opaqueness is especially problematical when it comes to cancer therapies such as chemotherapy that are infused intravenously in a hospital or clinic. The decision-making process, through which standard of care drug(s) are recommended and ultimately prescribed, can cross a line that favors profit over true patient value.